The combination strategy is designed to simultaneously block proliferative signaling through RAS inhibition and disrupt tumor survival pathways via elraglusib’s GSK-3ß inhibition, potentially ...

A new cohort study suggests that Medicaid expansion is associated with a lower mortality risk among patients with pancreatic ...

Pancreatic cancer is one of the most dangerous forms of cancer in the world. It is known for being very difficult to detect and very hard to treat. I. n many cases, the disease gr ...

Pancreatic cancer is one of the most dangerous forms of cancer in the world. It often develops quietly and is very difficult ...

Now, a Carnegie Mellon University spinout company aims to identify patients at high risk for lung, liver and pancreatic ...

A newly discovered gene switch may help turn chemotherapy-resistant pancreatic cancer into a treatable disease.

A team of researchers from Taiwan has developed PanMETAI, an AI-powered platform that analyzes metabolic fingerprints in a ...

Sylvester Comprehensive Cancer Center, part of the University of Miami Health System, has sponsored PanCAN PurpleStride for ...

Can-Fite BioPharma (CANF) stock jumped 107% after namodenoson successfully completed Phase 2a safety testing in 20 pancreatic cancer patients.

Researchers at Duke-NUS Medical School have identified a molecular switch controlled by the protein GATA6 that determines whether pancreatic cancer cells respond to chemotherapy or become resistant.

Oregon Health & Science University researchers have found that certain nerves that play an integral role in the body's "fight or flight" stress response can support pancreatic tumor growth. These ...

Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more ...